» Articles » PMID: 39511496

Diagnostic Performance of Typhidot RDT in Diagnosis of Typhoid Fever and Antibiotic Resistance Characterisation in a Cross-sectional Study in Southern Ghana

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2024 Nov 7
PMID 39511496
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Typhoid fever remains a significant public health problem contributing to significant misapplication of antibiotics in Ghana. However, there is little data on the accuracy of the commonly used serology based rapid diagnostic Typhidot test kit (Typhidot RDT) for confirming typhoid fever.

Methods: We conducted a study to assess the diagnostic accuracy of Typhidot RDT in seven clinical facilities across five regions in Southern Ghana. A total of 258 participants, clinically diagnosed with typhoid fever, were enrolled in this study. Blood and stool samples were obtained for culture, Typhidot and PCR assays. Disc diffusion antibiotic sensitivity was performed to determine the resistance pattern of Salmonella enterica isolates from positive blood and stool cultures.

Results: Recovery of S. enterica isolates was higher from stool samples (14.7%) in comparison to blood samples (1.6%). The sensitivity and specificity of Typhidot compared to blood and stool cultures was 35% (19.94%-52.65%) and 45% (38.67%-51.45%), respectively. Compared to PCR, the Typhidot had a sensitivity and a specificity of 61% and 53%, respectively. Resistance phenotyping of isolates showed broad sensitivity to the front-line antibiotics used. Resistance to ampicillin (10%), cotrimoxazole (7%), azithromycin and ciprofloxacin (< 5%) was found in some isolates.

Conclusions: These findings suggest sub-optimal performance of the Typhidot RDT for diagnosis of typhoid in Ghana with a higher chance for misdiagnosis and misapplication of antibiotics. The high proportion of isolates recovered from stool culture is consistent with the pathophysiology of bacterial shedding during the acute phase of infection, which provides a window of opportunity to control typhoid transmission.

References
1.
von Kalckreuth V, Konings F, Aaby P, Adu-Sarkodie Y, Ali M, Aseffa A . The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies. Clin Infect Dis. 2016; 62 Suppl 1:S9-S16. PMC: 4772831. DOI: 10.1093/cid/civ693. View

2.
Ajibola O, Mshelia M, Gulumbe B, Eze A . Typhoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel of Progress?. Medicina (Kaunas). 2018; 54(2). PMC: 6037256. DOI: 10.3390/medicina54020023. View

3.
Dyson Z, Klemm E, Palmer S, Dougan G . Antibiotic Resistance and Typhoid. Clin Infect Dis. 2019; 68(Suppl 2):S165-S170. PMC: 6405283. DOI: 10.1093/cid/ciy1111. View

4.
Goay Y, Chin K, Tan C, Yeoh C, Jaafar J, Zaidah A . Identification of Five Novel Typhi-Specific Genes as Markers for Diagnosis of Typhoid Fever Using Single-Gene Target PCR Assays. Biomed Res Int. 2016; 2016:8905675. PMC: 5126401. DOI: 10.1155/2016/8905675. View

5.
Wasihun A, Wlekidan L, Gebremariam S, Welderufael A, Muthupandian S, Haile T . Diagnosis and Treatment of Typhoid Fever and Associated Prevailing Drug Resistance in Northern Ethiopia. Int J Infect Dis. 2015; 35:96-102. DOI: 10.1016/j.ijid.2015.04.014. View